Introduction Semaglutide Is rapidly emerging as a revolutionary medication in the treatment of type 2 diabetes, obesity, and related cardiovascular conditions. Initially designed to improve blood sugar control in people with type 2 diabetes, Semaglutide is a part of the GLP-1 (glucagon-like peptide-1) receptor agonists class of drugs. This class https://cancer-second-opinion83603.dsiblogger.com/64478118/semaglutide-a-revolutionary-treatment-for-diabetes-obesity-and-cardiovascular-health